Insights into Cellectis Voting Rights and Shareholder Information
Understanding Cellectis Share Capital and Voting Rights
Cellectis is continually updating its stakeholders on important aspects of share capital and voting rights. These updates are essential for investors who keep a keen eye on how their investments are being managed and allocated.
Recent Share Capital Information
As of the end of last month, the total number of shares in Cellectis' capital stands impressively at 100,093,873. This figure represents a vital piece of information for potential investors and current shareholders alike.
Total Voting Rights Update
Along with the noteworthy capital figure, Cellectis also reported that the total number of voting rights currently available is 88,569,683. This aspect is crucial as it defines the power shareholders have in making pivotal decisions that influence the company’s direction.
Importance of Voting Rights
Voting rights are a fundamental component for any shareholder as they determine who gets a say in various corporate decisions, from electing board members to deciding on major shifts in company strategy. Understanding these rights empowers shareholders to engage actively in the governance of Cellectis.
Contacting Cellectis for More Information
Cellectis encourages shareholders and interested parties to reach out for any queries or further clarification regarding share capital and voting rights. Effective communication is integral to maintaining a transparent relationship between the company and its shareholders.
Media Inquiries
For media-related questions, Pascalyne Wilson serves as the Director of Communications. She can be contacted at +33 (0)7 76 99 14 33 or via email at media@cellectis.com.
Investor Relations
Investor relations at Cellectis are managed by Arthur Stril, the Interim Chief Financial Officer. Investors can reach out at +1 (347) 809 5980 or via email at investors@cellectis.com. This open line of communication helps ensure that investors remain informed about key developments affecting their stakes.
Conclusion on Cellectis’ Share Information
Cellectis' transparency in sharing the details of share capital and voting rights showcases their commitment to maintaining an engaged and informed shareholder base. Knowledge about one’s investment is crucial in today's fast-paced market environment, making these updates invaluable for existing and potential investors.
Frequently Asked Questions
What is the total number of shares in Cellectis' capital?
The total number of shares in Cellectis' capital is 100,093,873.
How many voting rights does Cellectis currently have?
Cellectis currently has 88,569,683 voting rights.
Who can I contact for media inquiries regarding Cellectis?
Media inquiries can be directed to Pascalyne Wilson, Director of Communications, at +33 (0)7 76 99 14 33.
Who is responsible for investor relations at Cellectis?
Arthur Stril, the Interim Chief Financial Officer, is responsible for investor relations at Cellectis.
Why are voting rights important for shareholders?
Voting rights allow shareholders to participate in important decisions regarding the company's governance and future direction, empowering them in their investment journey.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.